Articles related toPublic Health and Primary Care

Review of medication-assisted treatment for opioid use disorder

Nessreen Ghanem, OMS IV; Devin Dromgoole, OMS IV; Ahmad Hussein, MBS; and Richard T. Jermyn, DO, FAAPMR
This review will define the components of medication-assisted treatment (MAT), consider the impact of MAT in the primary care setting, and identify barriers to effective MAT.
J Osteopath Med; 122(7): 367-374

Associations between diabetes-related distress and predicted cardiovascular complication risks in patients with type 2 diabetes

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP; Rachael Mullin, OMS IV; Joy A. Moverley, MPH, PA-C, DHSc; and Jay H. Shubrook, DO
Diabetes-related distress (DRD) is experienced by nearly 50% of people with diabetes at any given time in their diagnosis. The effects of low socioeconomic status and lacking access to resources can increase DRD. In addition, cardiovascular (CV) complications associated with diabetes are associated with higher DRD scores. This study evaluated the associations between DRD and predicted CV risks in participants with type 2 diabetes.
J Osteopath Med; 122(6): 319-326

Primary care providers’ experiences treating low back pain

Sondos Al Sad, MD, MPH; and Amanda R. Start, PhD
This study aims to explore primary care providers' experiences and practice patterns regarding low back pain in females compared to males in healthcare settings within the United States.
J Osteopath Med; 122(5): 263-269

Evaluating the effectiveness of countywide mask mandates at reducing SARS-CoV-2 infection in the United States

Hadie Islam, BS; Amina Islam; Alan Brook, MD; and Mohan Rudrappa, MD
This study aims to analyze the effectiveness of mask mandates in small US counties and places where the population density may not be as high as in larger urban counties and to determine the efficacy of countywide mask mandates in reducing daily COVID-19 infection.
J Osteopath Med; 122(4): 211-215

A novel movement system screen for primary care providers: a multisite, observational study

Christine Kettle, DPT; Lauren McKay, DO; Anthony M. Cianciolo, DO; Stephen M. Kareha, DPT, ATC, PhD; and Cara E. Ruggeri, DO
The authors evaluated whether a screening tool would be able to accurately screen individuals for movement system disorders (MSDs), explore comorbidities that may predict the prevalence of MSDs, and identify why people do not discuss these problems with their primary care provider.
J Osteopath Med; 122(3): 159-166

Glycemic control is associated with lower odds of mortality and successful extubation in severe COVID-19

Jay M. Pescatore, DO; Juan Sarmiento, MD; Ruben A. Hernandez-Acosta, MD; Britt Skaathun, PhD, MPH; Nancy Quesada-Rodriguez, MD; and Katayoun Rezai, MD
Corticosteroids, specifically dexamethasone, have become the mainstay of treatment for moderate to severe COVID-19. This study aims to analyze the association between corticosteroids and COVID-19–related outcomes in patients admitted to the medical ICU for COVID-19 pneumonia.
J Osteopath Med; 122(2): 111-115

Bursting the bubble: hereditary spherocytosis masking poor glycemic control

Ashley Gordon, DO; Deep Pachu, MD; and Matthew J. Hadfield, DO
The authors present a case of a patient who was found to have hereditary spherocytosis (HS) after developing nephrotic range proteinuria. The patient had diabetes that was previously thought to be well controlled, but his HS was masking his poor glycemic control. This case highlights the importance of understanding the limitations of the hemoglobin A1c in managing patients with diabetes.
J Osteopath Med; 122(1): 65-68

A pilot of a modified diabetes prevention program in Quito, Ecuador

Susana Alvear Durán, MD, MPH; Galo Sanchez-del-Hierro, MD, PhD; Diego Gomez-Correa, MD; Andrés Enriquez, MD; Enver Sanchez, MD; Melissa Belec, DO, MPH; Sharon Casapulla, EdD, MPH; Mario J. Grijlava, PhD; and Jay H. Shubrook, DO
Diabetes has become a global noninfectious pandemic with rates rapidly rising around the globe. The major drivers of this increase in type 2 diabetes are obesity, an increase in processed foods, and a decrease in physical activity. In the United States, the National Diabetes Prevention Program has proven to be an effective lifestyle intervention to delay or prevent new-onset type 2 diabetes. However, there is limited evidence that such a lifestyle program will work in a South American community. This pilot program aims to determine if a modified version of the Centers for Disease Control and Prevention Diabetes Prevention Program would be feasible in an Ecuadorian population.
J Osteopath Med; 121(12): 905-911

A renaissance in the treatment of diabetic kidney disease, hypertension in chronic kidney disease, and beyond

Jordana Yahr, DO; Juan Calle, MD; and Jonathan J. Taliercio, DO
Chronic kidney disease (CKD) affects approximately 15% of the US population and is associated with significant cardiovascular morbidity and mortality. In this article, the authors define CKD staging, review new hypertension and diabetic guidelines for CKD patients, and discuss major trials for new potential therapies in CKD, particularly diabetic kidney disease. They also provide practical guidance for primary care physicians to diagnose CKD and implement these agents early in the disease course to prevent the progression of disease and reduce the morbidity and mortality of this vulnerable population.
J Osteopath Med; 122(1): 55-63

Masqueraders: how to identify atypical diabetes in primary care

Sumera Ahmed, MD; Sana Saeed, MS; and Jay H. Shubrook, DO
While type 1 diabetes, type 2 diabetes, and gestational diabetes are most frequently encountered, there are many other types of diabetes with which healthcare providers are less familiar. These atypical forms of diabetes make up nearly 10% of diabetes cases and can masquerade as type 1 or 2 diabetes mellitus (T1DM or T2DM), and the treatment may not be optimized if the diagnosis is not accurate. This paper will detail the defining characteristics of each atypical form and demonstrate how they can masquerade as T1DM or T2DM.
J Osteopath Med; 121(12): 899-904